Home›Search›Cancer Biotherapy and Radiopharmaceuticals

Cancer Biotherapy and Radiopharmaceuticals

Mary Ann Liebert Inc. · United States

ISSN1084-9785eISSN1557-8852

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q2+18

Total53

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

0.55

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.57

Total Works

2,489

Total Citations

43,381

2yr Mean Citedness

0.84

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on the application of radiopharmaceuticals and targeted radionuclide therapy for cancer treatment. It explores advancements in drug delivery, including ultrasound-assisted methods and nanoformulations, to enhance therapeutic efficacy and minimize toxicity. The journal also covers diagnostic imaging techniques, such as PET/CT and SPECT/CT, for tumor detection and staging, and investigates the safety and adverse effects of various cancer therapies.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 50% in field

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published—

Annual Volume~ 64 articles / year

StatusActive

Total Publications2,489

Publisher OrgMary Ann Liebert, Inc.

Visit Journal Website

Submission Info

Publishing ModelSubscription

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Mary Ann Liebert Inc.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1084-9785 / 1557-8852

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q2

Radiology, Nuclear Medicine and ImagingQ2

Cancer ResearchQ3

OncologyQ3

PharmacologyQ3

Subject Classification

Web of Science Categories

Medicine, Research & ExperimentalOncologyPharmacology & PharmacyRadiology, Nuclear Medicine & Medical Imaging

Scopus Categories

PharmacologyRadiology, Nuclear Medicine and ImagingCancer ResearchOncologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Radiopharmaceutical Chemistry and ApplicationsMedical Imaging Techniques and ApplicationsMonoclonal and Polyclonal Antibodies ResearchCancer-related molecular mechanisms researchImmunotherapy and Immune Responses